Details for New Drug Application (NDA): 084279
✉ Email this page to a colleague
NDA 084279 describes COL-PROBENECID, which is a drug marketed by Watson Labs and is included in one NDA. It is available from one supplier. Additional details are available on the COL-PROBENECID profile page.
The generic ingredient in COL-PROBENECID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
The generic ingredient in COL-PROBENECID is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
Summary for 084279
| Tradename: | COL-PROBENECID |
| Applicant: | Watson Labs |
| Ingredient: | colchicine; probenecid |
| Patents: | 0 |
Suppliers and Packaging for NDA: 084279
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| COL-PROBENECID | colchicine; probenecid | TABLET;ORAL | 084279 | ANDA | Actavis Pharma, Inc. | 0591-5325 | 0591-5325-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG;500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
